Pictured: Paul Sabbatini
Q&A
By Esther Napolitano, BS, Science Writer/Editor  |  Wednesday, September 24, 2014

Medical oncologist Paul Sabbatini sheds light on how phase I clinical trials are conducted at Memorial Sloan Kettering and how to determine whether patients may be eligible for one.

Pictured: Experimental Brain Tumor
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, September 18, 2014

Researchers have engineered a gene into therapeutic cells that allows them to turn off tumor growth if some of the cells become cancerous.

Thoracic surgeon Bernard Park.
Ask the Expert
By Andrea Peirce, BA, Writer/Editor  |  Thursday, August 28, 2014

Less trauma and faster recovery are among the reasons that thoracic surgeon Bernard Park says people should consider robotic surgery for removing a cancer in the chest.

pictured: David Jones
Q&A
By Christina Pernambuco-Holsten, MA  |  Wednesday, August 13, 2014

David Jones, Chief of the Thoracic Surgery Service, talks about what makes MSK thoracic surgeons special and where he believes the future of treatment for cancers of the lung and esophagus is headed.

Pictured: Richard O’Reilly
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Thursday, July 31, 2014

A study shows that treatment of severe combined immunodeficiency (SCID) with stem cell transplantation is very effective, especially if done early.

Pictured: Robotic surgery
In the Clinic
By Eva Kiesler, PhD, Science Writer/Editor  |  Thursday, July 24, 2014

Memorial Sloan Kettering researchers have found that the use of surgical robots does not lead to better outcomes in patients undergoing radical cystectomy for bladder cancer, bringing into question the added costs of the tools.

Pictured: Gabriela Chiosis
Finding
By Celia Gittelson, BA  |  Thursday, July 17, 2014

A small molecule discovered at MSK called PU-H71 blocks the growth of cancer cells and enables doctors to image tumors.

Pictured: Vivian Strong
Cancer Guide
By Andrea Peirce, BA, Writer/Editor  |  Tuesday, June 24, 2014

Memorial Sloan Kettering diagnoses and treats more people with stomach cancer than any other cancer center in the nation.

Pictured: Peter Allen
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Wednesday, June 18, 2014

A new drug could make pancreatic surgery safer by reducing the risk of a grave complication.

Pictured: Larry Norton
Video
By Helen Garey, MPH, Freelance Writer  |  Tuesday, June 10, 2014

Memorial Sloan Kettering experts say that new information about the biology of breast cancer is revolutionizing the way they look at the disease.

Pictured: Jedd Wolchok
MSK at ASCO
By Media Staff  |  Wednesday, June 4, 2014

Our experts offer their perspective in major media outlets on recent research into drug- and cell-based immunotherapies for cancer.

Pictured: Helen McArthur
In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Tuesday, June 3, 2014

The treatment combines a technique called cryoablation, or freezing of the tumor, with an immunotherapy drug.

Pictured: David Solit
Profile
By Julie Grisham, MS, Science Writer/Editor  |  Tuesday, May 27, 2014

David Solit, Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, discusses how working with cancer patients drives him to develop more-effective, personalized cancer treatments.

Pictured: Tari King
In the News
By Jennifer Bassett, MA, Writer/Editor  |  Thursday, May 22, 2014

Memorial Sloan Kettering breast surgeon Tari King talks to CBS Online about a new study suggesting double mastectomies may be performed unnecessarily in many women.

Pictured: Mark Kris
Finding
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, May 21, 2014

A new study has found that driver mutations can be found in about two-thirds of lung adenocarcinomas, suggesting options for treatment with targeted therapies.

Center News

Stay Informed

Get the latest information about cancer care and research every month.